F20-F29 F31 F32.2 F32.3 F33.2 F33.2 F60.31
Conditions
Interventions
Group 1: Treatment as Usual (TAU):
The TAU group serves as the control group, in which patients receive standard care in accordance with routine clinical practices and guidelines. Patients are provide
Sponsors
Universitätsklinikum Hamburg Eppendorf
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patients receiving (partial) inpatient psychiatric treatment, or those attending psychiatric outpatient clinics (Psychiatrische Institutsambulanzen) within six months after discharge from an inpatient setting, with a diagnosis of severe mental illness (SMI): schizophrenia spectrum disorders, bipolar disorder, severe depression, or emotionally unstable personality disorder.
Exclusion criteria
Exclusion criteria: Insufficient knowledge of the German language
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary Endpoint: Empowerment Measurement method: Empowerment (EPAS) Time point: T2 Description: The questionnaire assesses empowerment as a process of increasing individuals’ capacity to control their own lives, captured across five dimensions: everyday life, social relationships, participation in treatment, self-efficacy, and self-esteem. | — |
Secondary
| Measure | Time frame |
|---|---|
| Self-efficacy Measurement method: General Self-Efficacy Expectancy (SWE) Time point: T2 Description: The questionnaire measures self-efficacy expectancy, i.e., the confidence in being able to cope with difficult situations, with success attributed to one’s own competence. Recovery Measurement method: Recovery (RAS-29) Time point: T2 Description: A questionnaire assessing individual recovery. It comprises four subscales: doing things that are important to me; looking forward; mastering my illness; connectedness and belonging. Social Inclusion Measurement method: Social Inclusion (SIS) Time point: T2 Description: A measure of social inclusion. The questionnaire includes three subscales: social isolation, social relationships, and social acceptance. Participation in Treatment (DCS) Measurement method: Participation in Treatment (DCS) Time point: T2 Description: The Decisional Conflict Scale (DCS) was developed to operationalize the quality of medical decision-making and is primarily intended for the evaluation of decision aids or other decision-support interventions. The questionnaire comprises five subscales: uncertainty, feeling uninformed, unclear values, lack of support, and ineffective decision-making. | — |
Countries
Germany
Contacts
Public ContactCandelaria Mahlke
Universitätsklinikum Hamburg Eppendorf
Outcome results
None listed